Skip to main content

Communicating Clearly About Medicines Proceedings of a Workshop (2017) / Chapter Skim
Currently Skimming:

6 Reflections on the Day
Pages 85-88

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 85...
... These comments, she said, led her to wonder if there are options akin to nurse advice lines that could be an accountable place for patients and caregivers to go to get answers when they are ready to hear information or if they have questions they need answered after throwing away the materials the pharmacist handed them with their prescription. Another message from the first panel that Brach highlighted was the importance of the care team and the need to make better use of all-care team members as sources of information.
Read the entire page →
From page 86...
... She credited her roundtable colleague Laurie Myers of Merck with blazing the trail for having dedicated health literacy teams in pharmaceutical companies. She then noted that the organization's seriousness about health literacy started to change when she was given that official title, so she recommended that others doing health literacy work in pharmaceutical companies should advocate for a job title that has "health literacy" in it.
Read the entire page →
From page 87...
... Informed consent is another area that needs more attention from a health literacy perspective, as is the development of instructions of use for combination products. Myers also thought it is imperative to understand the met and unmet needs of patients who desire future products in terms of patientreported outcomes and other quality measures.
Read the entire page →
From page 88...
... He also recalled that in May 2017, he heard FDA Commissioner Robert Califf suggest that postmarketing surveillance efforts may be insufficiently multidimensional to address contemporary drug safety-related issues and may need to be expanded. "I envision an important role for the roundtable to gather evidence and provide guidance about how to embed a health literacy perspective as part of revamped postmarketing surveillance initiatives," wrote Logan.
Read the entire page →

Key Terms

  • literacy perspective
  • postmarketing surveillance
  • pharmaceutical companies
  • bring health
  • surveillance efforts

  • nation products
  • cognitive challenges
  • introducing lee
  • heard fda
  • hear information

  • health record
  • trials materials
  • introducing health
  • underrepresented populations
  • executive function

  • impact medication
  • literacy community
  • patients benefit
  • clinical trials
  • pharmacist handed

  • team based
  • colleague laurie
  • eli lilly
  • future products
  • oral health

  • doing health
  • job title
  • medication adherence
  • newly appointed
  • califf suggest


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.